SecBot SecBot
Home › SEC Filings › Press Releases

Press Releases

33 reports analyzed by SecBot AI · browse by date or by stock
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
TickerTypeSentimentImpactSummaryDate
BNGOPRESS-RELEASEbearish6/10Bionano Genomics reported Q4 and full-year 2025 results with declining revenue and net losses, though gross margins and Mar 23, 2026
NTLAPRESS-RELEASEneutral3/10Intellia Therapeutics granted inducement awards of 16,500 RSUs to six new employees outside its shareholder-approved equMar 6, 2026
NTLAPRESS-RELEASEbullish8/10Intellia Therapeutics announced that the FDA has lifted the clinical hold on its Phase 3 MAGNITUDE trial for nexiguran zMar 2, 2026
« Previous Page 2 of 2